Profil
Theo H.
Walthie is currently a Member-Supervisory Board at LANXESS Deutschland GmbH.
Previously, he served as Chairman at NBE-Therapeutics AG.
He also held the position of Global Business President-Hydrocarbons & Energy at The Dow Chemical Co. from 1970 to 2007.
Additionally, he was a Member-Supervisory Board at Lanxess AG from 2010 to 2022.
Mr. Walthie obtained his undergraduate degree from Delft University of Technology.
Aktiva positioner av Theo H. Walthie
| Företag | Position | Start |
|---|---|---|
LANXESS Deutschland GmbH
LANXESS Deutschland GmbH Chemicals: SpecialtyProcess Industries Produces and sells chemicals | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Theo H. Walthie
| Företag | Position | Slut |
|---|---|---|
| LANXESS AG | Direktör/Styrelseledamot | 2022-05-25 |
NBE-Therapeutics AG
NBE-Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops antibody drug conjugates and advancing targeted cancer therapies | Ordförande | 2020-08-10 |
| DOW CHEMICAL COMPANY (THE) | Företagsledare/Principal | 2007-01-01 |
Theo H. Walthies utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
The Dow Chemical Co.
The Dow Chemical Co. Chemicals: Major DiversifiedProcess Industries Manufactures specialty additives, modifiers and plastic polyethylene products | Process Industries |
LANXESS AG
LANXESS AG Chemicals: Major DiversifiedProcess Industries Produces and sells specialty additives, intermediaries and engineering materials | Process Industries |
Delft University of Technology
Delft University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LANXESS Deutschland GmbH
LANXESS Deutschland GmbH Chemicals: SpecialtyProcess Industries Produces and sells chemicals | Process Industries |
NBE-Therapeutics AG
NBE-Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops antibody drug conjugates and advancing targeted cancer therapies | Health Technology |
















